- Home
- CINGW vs REGCO Comparison
CINGW vs REGCO Comparison
Compare CINGW & REGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINGW
- REGCO
- Stock Information
- Founded
- CINGW N/A
- REGCO N/A
- Country
- CINGW United States
- REGCO United States
- Employees
- CINGW 13
- REGCO 500
- Industry
- CINGW Biotechnology: Pharmaceutical Preparations
- REGCO
- Sector
- CINGW Health Care
- REGCO
- Exchange
- CINGW Nasdaq
- REGCO Nasdaq
- Market Cap
- CINGW N/A
- REGCO N/A
- IPO Year
- CINGW 2021
- REGCO N/A
- Fundamental
- Price
- CINGW $0.04
- REGCO $22.61
- Analyst Decision
- CINGW
- REGCO
- Analyst Count
- CINGW 0
- REGCO 0
- Target Price
- CINGW N/A
- REGCO N/A
- AVG Volume (30 Days)
- CINGW N/A
- REGCO N/A
- Earning Date
- CINGW N/A
- REGCO N/A
- Dividend Yield
- CINGW N/A
- REGCO N/A
- EPS Growth
- CINGW N/A
- REGCO N/A
- EPS
- CINGW N/A
- REGCO N/A
- Revenue
- CINGW N/A
- REGCO N/A
- Revenue This Year
- CINGW N/A
- REGCO N/A
- Revenue Next Year
- CINGW N/A
- REGCO N/A
- P/E Ratio
- CINGW N/A
- REGCO N/A
- Revenue Growth
- CINGW N/A
- REGCO N/A
- 52 Week Low
- CINGW N/A
- REGCO N/A
- 52 Week High
- CINGW N/A
- REGCO N/A
- Technical
- Relative Strength Index (RSI)
- CINGW N/A
- REGCO 57.83
- Support Level
- CINGW N/A
- REGCO $22.10
- Resistance Level
- CINGW N/A
- REGCO $23.12
- Average True Range (ATR)
- CINGW 0.00
- REGCO 0.37
- MACD
- CINGW 0.00
- REGCO 0.09
- Stochastic Oscillator
- CINGW 0.00
- REGCO 69.09
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.